Thanks Bill,
Paid advertising, but i guess most reports are in some way.
Might have a specific target audience though, perhaps for SC-1.
I'm sure a few smaller Asian investors could buy the whole thing at the moment.
I wonder what the 'investment banking services' were?
Antibody-Based Therapy is Poised to be the Fastest-Growing Segment of New Cancer Drug Development, page-2
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.45M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 330704 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 5312414 | 5 |
View Market Depth
| Last trade - 16.12pm 03/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable